Pine Mix Allergy Shots: What's Actually in Your Vial?
Pine-mix is the standard prescription format when pine SCIT is indicated — bundling up to four Pinus species (commonly P. strobus, P. ponderosa, P. taeda, P. elliottii) using the near-complete intra-genus cross-reactivity established by Gastaminza 2009. No FDA-standardized pine extract exists and no SCIT RCT has been published for any pine-mix preparation; potency varies between lots and manufacturers.
Pine Mix Allergy Immunotherapy: How It Works
Allergy immunotherapy is the only long-term treatment that re-trains the immune system to stop overreacting to pine mix — rather than just masking symptoms with antihistamines or steroids. By gradually exposing the body to controlled doses of pine mix allergen, immunotherapy shifts the underlying allergic response and produces relief that often outlasts treatment by 7–10 years.
There are two evidence-based forms of pine mix immunotherapy used today, both built on the same desensitization principle but delivered very differently.
of sustained relief after a complete immunotherapy course — the only allergy treatment with proven long-term effect after stopping.
Allergy Shots (SCIT)
Weekly injections of pine mix extract in a clinic, escalating over 3–6 months until a maintenance dose is reached. Continued monthly for 3–5 years. Longest clinical track record for pine mix allergy.
- Strongest evidence base for severe and polysensitized patients
- Covered by most insurance plans
- Requires 50–100+ in-person clinic visits across the full course
Allergy Drops / Tablets (SLIT)
Daily drops or dissolvable tablets containing pine mix extract, held under the tongue at home. Same desensitization principle, delivered without injections. WHO-recognized as an effective form of allergy immunotherapy since 2001.
- Taken at home — no weekly clinic trips, no needles
- Lower systemic reaction rate than allergy shots
- Curex offers prescription pine mix immunotherapy drops with allergist oversight
The rest of this page goes deep on allergen-specific immunotherapy with shots — protocol, efficacy data, side effects, and cost. If you’d rather skip the clinic and treat pine mix allergy with at-home drops, see how Curex sublingual immunotherapy compares below.
What is Pine Mix?
The biology, taxonomy, and clinical fingerprint of Pine Mix — the foundation of how SCIT targets it.
Pine-mix SCIT vials typically combine pollen extracts from 2–4 Pinus species, relying on near-complete intra-genus cross-reactivity to cover regional exposures from Maine to Florida to the Rockies.
- Scientific name
- Pinus spp. (P. strobus, P. ponderosa, P. taeda, P. elliottii mixture)
- Family
- PinaceaePine family
- Type
- Multi-species conifer tree pollen blend
- Native to
- Pan-US distribution across constituent species; Northeast, Rocky Mountains, and Southeast
- Allergen proteins
- No IUIS-named allergen registered for any US Pinus species; IgE-binding bands at 42 kDa and 6–8 kDa identified across Pinus by Gastaminza et al. 2009
- Particle size
- 60–100 μm across constituent species (saccate, two air sacs)
- Avoidance difficulty
- Very difficult
How Pine Mix Allergy Presents
Symptoms by body system — useful for distinguishing Pine Mix sensitivity from overlapping allergies and infections.
Respiratory
- Seasonal rhinitis coinciding with April–June pine pollen events nationally
- Nasal congestion and postnasal drip during the 6–8 week pollen release window
- Mild asthma exacerbation in confirmed Pinus-sensitized individuals
- Symptom overlap with concurrent oak, birch, and grass seasons — common source of misattribution
Ocular
- Itchy, watery eyes during peak visible pollen events
- Conjunctival redness after prolonged outdoor exposure during pine season
- Mild periorbital swelling in sensitized individuals
Dermal
- Contact urticaria from high-density pollen deposition (uncommon)
- Skin irritation from pine resin — distinct from IgE-mediated pollen allergy
- Mild hives in patients with documented Pinus sensitization
Systemic
- Fatigue during extended pollen season from disrupted sleep and chronic nasal inflammation
- Reduced outdoor productivity during pollen peaks across multiple climate zones
- Symptom burden often higher than sensitization rate would predict — concurrent allergens are the explanation
Patients ask me why their pine shot is a mix if they're only allergic to white pine. The honest answer is that intra-pine cross-reactivity is essentially complete, the extracts are non-standardized, and we don't have a single RCT to tell us whether prescribing four pines together adds clinical benefit over one. We prescribe the mix because that's what's available.
When & Where Pine Mix Peaks
Allergen intensity by month and by state. Useful for timing SCIT start dates and travel planning.
12-Month Intensity
Peak: April–June across the US, with earlier release (February–March) for Southeast species like loblolly· Constituent species span 12+ weeks of combined release across all US regions
US Exposure Map
14 high-intensity statesWhat Pine Mix Cross-Reacts With
Patients sensitized to one allergen often react to others sharing similar proteins. This map shows the documented molecular overlaps.
The entire clinical rationale for pine-mix SCIT rests on near-complete intra-Pinus cross-reactivity documented by IgE-blot and RAST inhibition studies — the mix adds species but not meaningfully distinct allergen proteins.
Is SCIT Right for Your Pine Mix Allergy?
Answer five questions to understand whether pine-mix allergy shots are the right immunotherapy target for your symptoms.
How severe are your spring pollen symptoms during April–June?
The Pine Mix SCIT Protocol
Pine-mix SCIT uses the standard inhalant build-up schedule, but with an important regulatory caveat: no FDA-standardized pine extract exists, meaning potency is expressed in PNU or w/v and varies between manufacturers and lot numbers.
Your allergist titrates the pine-mix vial from a dilute starting concentration upward over 16–24 weeks. Because pine extract potency is non-standardized, skin-test reactivity at the starting visit informs the initial concentration. A 30-minute observation period is required after each injection. When a new vial lot is opened, dose may be stepped back to account for lot-to-lot variability.
At the target maintenance dose, injections shift to monthly clinic visits. Lot-to-lot potency variability (documented at >2-fold in CBER reference materials for non-standardized pine extracts) means your allergist may adjust dose with each new vial set. Ongoing symptom diary review is prudent given the absence of objective efficacy surrogates.
After completing the standard course, some patients achieve durable tolerance; others require continued therapy. Because no RCT defines an evidence-based stopping rule for pine-mix SCIT, discontinuation is based on symptom trajectory, skin test evolution, and shared decision-making with your allergist.
Extract Concentration Ladder
You progress through each vial during build-up. Concentration increases ~10x per step.
What the Research Shows for Pine Mix SCIT
No randomized controlled trial has been published for any pine-mix SCIT preparation — this is the most significant evidence gap in the pine allergen group, given the large US patient population attributing spring symptoms to pine.
- Pinus sensitization in unselected pollen-allergic patients3%Bucholtz GA et al., J Allergy Clin Immunol, 1985, N=155
- IgE positivity in selected pine-allergic cohort69%Gastaminza G et al., Clin Exp Allergy, 2009, N=selected cohort
- Inhalant SCIT symptom reduction (class-level extrapolation)60%Cox L et al., JACI, 2011 — AAAAI Practice Parameter meta-summary
No pine-mix–specific RCT has been published as of this page's authoring date. The 3.2% Pinus sensitization rate in unselected populations (Bucholtz 1985) means most patients attributing spring symptoms to pine are reacting to concurrent allergens. For patients with confirmed pine-specific IgE, the inhalant SCIT class evidence provides a rationale — but the absence of RCT data is a key informed-consent point.
Ready to skip the surprise bills?
See if at-home allergy shots fit your allergies — a 2-minute quiz, designed by board-certified allergists, with flat monthly pricing and no clinic visits.
- 4.8/5Patient rating
- $129/moFlat pricing
- 50K+Patients treated
- HSA/FSAEligible
Pine Mix SCIT Side Effects
Pine-mix SCIT carries the standard inhalant SCIT side-effect profile. Non-standardized extract lot-to-lot variability can affect local reaction intensity when vials change — your allergist should consider dose adjustment with each new lot.
Local reactions
3 documentedSystemic reactions
3 documentedThe Bernstein et al. JACI 2010 fatality registry analysis found systemic reaction rates for non-standardized extracts are similar to standardized allergens, though harder to predict at new lots — supporting the dose-step practice when vials change.
SCIT vs Alternatives for Pine Mix
For patients with confirmed Pinus sensitization, pine-mix SCIT — now self-administered as a weekly at-home shot with Curex — sublingual drops, avoidance, and daily medications are the main choices, each with distinct cost, convenience, and evidence tradeoffs.
| Criterion | SCITBest | SLIT | Avoidance | Medications |
|---|---|---|---|---|
| Effectiveness | Moderate (no pine-mix RCT; inhalant class extrapolation) | Emerging; no pine-specific trial | Limited — airborne pollen unavoidable | Symptomatic relief only |
| 5-yr cost | $3,500–$15,000 | Varies by provider; offered as a general modality, not by Curex | Low | $500–$2,000/year |
| Duration | 3–5 years | 3–5 years | Ongoing | Indefinite |
| Convenience | Weekly at-home self-injection during build-up with Curex; first dose and dose changes supervised live over Zoom | Daily drops at home | HEPA filters, windows closed in season | Daily pills/sprays |
| Safety | 30-min self-observation; sterile-compounded serum with live Zoom supervision of dose changes; lot variability risk | Lower systemic reaction risk vs SCIT | Safe | Safe; sedation risk with antihistamines |
| Lasting effect | Possible lasting tolerance | Possible lasting benefit | No immune modification | No lasting effect |
SCITBest
SLIT
Avoidance
Medications
For patients with confirmed pine sensitization, Curex delivers pine-mix immunotherapy as a weekly at-home shot at $129/month instead of a weekly clinic schedule, with the first dose and every dose change supervised live over Zoom and a prescribed epinephrine auto-injector confirmed on hand; sublingual drops remain a separate needle-free modality, though injectable pine-mix preparations carry inherent lot-to-lot potency variability.
What Pine Mix SCIT Actually Costs
Most major insurers cover inhalant SCIT when ordered by a board-certified allergist with documented sensitization. Pine-mix extract is non-standardized — some plans require prior authorization. Verify coverage for CPT 95165 (extract preparation) specifically, as this is where plan variation is most common. Curex at-home IgE testing identifies specific pine mix sensitization before allergist consultations, eliminating the need for an initial skin-test visit.
Cost range varies by deductible, co-insurance, and clinic.
Verify these codes with your insurer to confirm coverage.
Flat monthly subscription — includes consult, prescription, and at-home dosing for sublingual immunotherapy.
See if you qualifyStop guessing about your pine mix allergy. Get a plan.
Take Curex’s 3-minute allergy quiz. A board-certified allergist will review your symptoms and recommend the right immunotherapy path for you — shots or drops.
Free quiz · Board-certified allergists · 50,000+ patients treated · HSA/FSA eligible
Pine Mix SCIT — Frequently Asked
Quick answers to the questions patients ask most before starting treatment.
Most US manufacturers supply a 4-pine mix containing Pinus strobus (white pine), Pinus ponderosa (ponderosa), Pinus taeda (loblolly), and Pinus elliottii (slash pine). Greer's commercial formulation includes these four species. ALK-Abelló and Jubilant HollisterStier offer similar compositions, though the exact blend varies by manufacturer and regional formulary. Because intra-Pinus cross-reactivity is near-complete by IgE inhibition (Gastaminza 2009), most allergists do not consider the species blend clinically significant — the mix is a practical compounding choice, not an immunologic necessity. Your allergist can specify which manufacturer's product is used in your vial set.
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.